| 1 |
Cognitive impairment in depression: a systematic review and meta-analysis
P L Rock, Jonathan Paul Roiser, Wim J. Riedel et al. · Psychological Medicine
ReviewOpen access |
29 Oct 2013 |
2,225 |
| 2 |
Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women
Susan Young et al. · BMC Psychiatry
Open access |
12 Aug 2020 |
613 |
| 3 |
Beneficial effects of docosahexaenoic acid on cognition in age‐related cognitive decline
Karin Yurko‐Mauro, Deanna McCarthy, Dror Rom et al. · Alzheimer s & Dementia
|
May 2010 |
575 |
| 4 |
Cognitive Function in a Randomized Trial of Evolocumab
Robert Patrick Giugliano, François Mach, Kenton H. Zavitz et al. · New England Journal of Medicine
Open access |
16 Aug 2017 |
494 |
| 5 |
Social cognitive dysfunction as a clinical marker: A systematic review of meta-analyses across 30 clinical conditions
Jack Cotter, Kiri T. Granger, Rosa Backx et al. · Neuroscience & Biobehavioral Reviews
ReviewOpen access |
24 Nov 2017 |
373 |
| 6 |
The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
the Synaptic Health Endpoints Working Group, Martí Colom‐Cadena, Tara L. Spires‐Jones et al. · Alzheimer s Research & Therapy
Open access |
2 Mar 2020 |
362 |
| 7 |
Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials
Terry E. Goldberg, Philip D. Harvey, Keith Andrew Wesnes et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Open access |
Mar 2015 |
345 |
| 8 |
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia
Golam Mohammed Khandaker, Jennifer H. Barnett, Ian R. White et al. · Schizophrenia Research
ReviewOpen access |
23 Jul 2011 |
312 |
| 9 |
Neuorpsychiatyric applications of CANTAB
Paul J. Fray, Trevor William Robbins, Barbara Jacquelyn Sahakian · International Journal of Geriatric Psychiatry
|
Apr 1996 |
308 |
| 10 |
Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial
Philip Scheltens, Jos W. R. Twisk, Rafael Blesa et al. · Journal of Alzheimer s Disease
Open access |
5 Jul 2012 |
306 |
| 11 |
Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin
Abarna Thiru, Daniel Nietlispach, Helen R. Mott et al. · The EMBO Journal
Open access |
5 Feb 2004 |
302 |
| 12 |
Heterochromatin Dynamics in Mouse Cells
Natalia V. Murzina, Alain Verreault, Ernest D. Laue et al. · Molecular Cell
Open access |
Oct 1999 |
297 |
| 13 |
Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic
AndréM.A. van Wageningen, Peter N. Kirkpatrick, Dudley H. Williams et al. · Chemistry & Biology
Open access |
Mar 1998 |
292 |
| 14 |
Early intervention in Alzheimer’s disease: a health economic study of the effects of diagnostic timing
Jennifer H. Barnett, Lily M. Lewis, Andrew D. Blackwell et al. · BMC Neurology
Open access |
7 May 2014 |
264 |
| 15 |
Effects of stress on decisions under uncertainty: A meta-analysis.
Katrin Starcke, Matthias Brand · Psychological Bulletin
|
2016 |
247 |
| 16 |
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
Alette M. Wessels et al. · JAMA Neurology
Open access |
25 Nov 2019 |
215 |
| 17 |
The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials
Joseph Firth, Scott B. Teasdale, Kelly Allott et al. · World Psychiatry
Open access |
9 Sep 2019 |
213 |
| 18 |
Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d
Deborah H. Brotherton, Venugopal Dhanaraj, Scott T. Wick et al. · Nature
|
Sep 1998 |
210 |
| 19 |
Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility
Marion Mortamais, Jessica A. Ash, John Harrison et al. · Alzheimer s & Dementia
Open access |
Oct 2016 |
204 |
| 20 |
Glutamate: The Master Neurotransmitter and Its Implications in Chronic Stress and Mood Disorders
Mia Michaela Pal · Frontiers in Human Neuroscience
Open access |
29 Oct 2021 |
196 |
| 21 |
Prefrontal and Monoaminergic Contributions to Stop-Signal Task Performance in Rats
Ausaf Bari, Adam C. Mar, David E. H. Theobald et al. · Journal of Neuroscience
Open access |
22 Jun 2011 |
194 |
| 22 |
The Paired Associates Learning (PAL) Test: 30 Years of CANTAB Translational Neuroscience from Laboratory to Bedside in Dementia Research
Jennifer H. Barnett, Andrew D. Blackwell, Barbara Jacquelyn Sahakian et al. · Current topics in behavioral neurosciences
Book chapter |
2015 |
189 |
| 23 |
Translational Approaches to Frontostriatal Dysfunction in Attention-Deficit/Hyperactivity Disorder Using a Computerized Neuropsychological Battery
Samuel Robin Chamberlain, Trevor William Robbins, Sophie Winder‐Rhodes et al. · Biological Psychiatry
|
4 Nov 2010 |
181 |
| 24 |
Evaluation of Speech-Based Digital Biomarkers: Review and Recommendations
Jessica Robin, John Harrison, Liam D. Kaufman et al. · Digital Biomarkers
Open access |
19 Oct 2020 |
180 |
| 25 |
Assessing cognitive function in clinical trials of schizophrenia
Jennifer H. Barnett, Trevor William Robbins, Verity C. Leeson et al. · Neuroscience & Biobehavioral Reviews
|
26 Jan 2010 |
177 |
| 26 |
The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction
Roger S. McIntyre, Michael W. Best, Christopher R. Bowie et al. · The Journal of Clinical Psychiatry
|
21 Aug 2017 |
175 |
| 27 |
The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial
Hasnain M. Dalal et al. · European Journal of Preventive Cardiology
Open access |
10 Oct 2018 |
172 |
| 28 |
Reinforcement and Reversal Learning in First-Episode Psychosis
Graham K. Murray, Fung Kei Cheng, Luke Clark et al. · Schizophrenia Bulletin
Open access |
16 Jul 2008 |
164 |
| 29 |
The Tragedy of the Risk-Perception Commons: Culture Conflict, Rationality Conflict, and Climate Change
Dan M. Kahan, Maggie Wittlin, Ellen M. Peters et al. · SSRN Electronic Journal
PreprintOpen access |
2011 |
151 |
| 30 |
The procedural learning deficit hypothesis of language learning disorders: we see some problems
Gillian West, Miguel Angel Vadillo, David R. Shanks et al. · Developmental Science
Open access |
2 Mar 2017 |
144 |
| 31 |
Targeting impulsivity in Parkinson’s disease using atomoxetine
Angie A. Kehagia, Charlotte R. Housden, Ralf Regenthal et al. · Brain
Open access |
3 Jun 2014 |
143 |
| 32 |
Comparing Web-Based and Lab-Based Cognitive Assessment Using the Cambridge Neuropsychological Test Automated Battery: A Within-Subjects Counterbalanced Study
Rosa Backx, Caroline Skirrow, Pasquale Dente et al. · Journal of Medical Internet Research
Open access |
11 Jun 2020 |
141 |
| 33 |
Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys
Alan Fine, Charles H.V. Hoyle, Catherine J Maclean et al. · Neuroscience
|
Sep 1997 |
138 |
| 34 |
Minute Effects of Sex on the Aging Brain: A Multisample Magnetic Resonance Imaging Study of Healthy Aging and Alzheimer's Disease
Anders M. Fjell, Lars Tjelta Westlye, Inge K. Amlien et al. · Journal of Neuroscience
Open access |
8 Jul 2009 |
131 |
| 35 |
Diffusion Tensor Metrics as Biomarkers in Alzheimer's Disease
Julio Acosta‐Cabronero, Stephanie Alley, Guy B. Williams et al. · PLoS ONE
Open access |
7 Nov 2012 |
130 |
| 36 |
Conditional learning and memory impairments following neurotoxic lesion of the CA1 field of the hippocampus
Rosalind M. Ridley, Carryl Timothy, Catherine J Maclean et al. · Neuroscience
|
Jul 1995 |
126 |
| 37 |
Personality and bipolar disorder: dissecting state and trait associations between mood and personality
Jennifer H. Barnett, Jue Huang, Roy H. Perlis et al. · Psychological Medicine
Open access |
7 Dec 2010 |
125 |
| 38 |
A randomised controlled trial of a facilitated home-based rehabilitation intervention in patients with heart failure with preserved ejection fraction and their caregivers: the REACH-HFpEF Pilot Study
Chim Choy Lang et al. · BMJ Open
Open access |
Apr 2018 |
124 |
| 39 |
Orientation-Tuned Surround Suppression in Mouse Visual Cortex
Matthew W. Self, Jeannette A. M. Lorteije, Joris Vangeneugden et al. · Journal of Neuroscience
Open access |
9 Jul 2014 |
122 |
| 40 |
Failure of Healthcare Provision for Attention-Deficit/Hyperactivity Disorder in the United Kingdom: A Consensus Statement
Susan Young et al. · Frontiers in Psychiatry
Open access |
19 Mar 2021 |
118 |
| 41 |
A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
Bruce H. Morimoto, Don E. Schmechel, Joe Hirman et al. · Dementia and Geriatric Cognitive Disorders
|
2013 |
115 |
| 42 |
Longitudinal Changes in Total Brain Volume in Schizophrenia: Relation to Symptom Severity, Cognition and Antipsychotic Medication
Juha M. Veijola et al. · PLoS ONE
Open access |
18 Jul 2014 |
114 |
| 43 |
A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease
for the REVERSE-SD Study Investigators, Niels D. Prins, John Harrison et al. · Alzheimer s Research & Therapy
Open access |
27 May 2021 |
112 |
| 44 |
Improving Response Inhibition in Parkinson’s Disease with Atomoxetine
Zheng Ye, Ellemarije Altena, Cristina Nombela et al. · Biological Psychiatry
Open access |
7 Feb 2014 |
111 |
| 45 |
Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project
Karen A. Ritchie, Michael T. Ropacki, Bruce Albala et al. · Alzheimer s & Dementia
Open access |
Oct 2016 |
108 |
| 46 |
The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation
James Rucker, Lindsey Marwood, Riikka-Liisa Johanna Ajantaival et al. · Journal of Psychopharmacology
Open access |
2022 |
106 |
| 47 |
Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study
Colin L. Sauder, Luke Allen, Elizabeth K. Baker et al. · Translational Psychiatry
Open access |
21 Nov 2022 |
105 |
| 48 |
Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort
Anja P. Husa, Jani Moilanen, Graham K. Murray et al. · Psychiatry Research
Open access |
12 Nov 2016 |
103 |
| 49 |
What Is the Role of Dietary Inflammation in Severe Mental Illness? A Review of Observational and Experimental Findings
Joseph Firth, Nicola Veronese, Jack Cotter et al. · Frontiers in Psychiatry
Open access |
15 May 2019 |
99 |
| 50 |
Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans
Nikolina Skandali, James Benedict Rowe, Valerie Voon et al. · Neuropsychopharmacology
Open access |
25 Sep 2018 |
96 |